HDAC9 and acute myeloid leukemia: In conclusion, our findings show that the HDAC inhibitor I1, as a chromatin-remodeling agent, has a marked anti-proliferative effect on MLLr-AML and MLLr-ALL cells by inducing cell differentiation.